Trial intelligence / Profile preview

Irbesartan vs Atenolol for Endothelial Function in Hypertensive Patients with Metabolic Syndrome

NCT00529750Phase 4Completed

Sponsor
Sanofi
Start
Jul 2002
Primary completion
Jan 2005
Modality
Small Molecules
01

Overview

A Phase 4 trial of irbesartan in hypertension (HTN), sponsored by Sanofi. Started Jul 2002; status: completed.

02

Drugs

irbesartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00529750.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00529750.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call